A randomized pilot study involving a small group of participants (54) with mild to moderate COVID-19 symptoms showed a trend toward a positive effect of LF, but differences in symptom or laboratory improvement between the control and the LF-treated groups were nonsignificant [ 189 ].
1
—
—